Skip to main content
SpringerLink
Log in

Diabetischer Fuß

  • Living reference work entry
  • First Online:
Operative und interventionelle Gefäßmedizin

Part of the book series: Springer Reference Medizin ((SRM))

  • 163 Accesses

Zusammenfassung

Das Krankheitsbild des diabetischen Fußes ist definiert als eine Infektion, Ulzeration und/oder Zerstörung des tiefen Weichteilgewebes mit neuropathologischen Befunden und einer unterschiedlich ausgeprägten peripheren Gefäßerkrankung der unteren Extremitäten (Schaper et al. 2003; International Working Group on the Diabetic Foot 2007). Wundheilungsstörungen der unteren Extremitäten bei einer diabetischen Stoffwechsellage stellen eine besondere Herausforderung dar. Statistisch gesehen wird weltweit alle 30 Sekunden eine dem Diabetes mellitus anzulastende Amputation an einer unteren Extremität durchgeführt. Weiterhin zeigt sich, dass ca. 20–40 % der Gesamtkosten einer Diabeteserkrankung auf die Therapie des diabetischen Fußsyndroms entfallen (Boulton et al. 2005). Studien belegen, dass 50–70 % aller Amputationen der unteren Extremitäten einer diabetischen Stoffwechsellage zuzuschreiben sind. Bei 85 % aller Amputationen, die an Diabetes mellitus erkrankten Patienten durchgeführt wurden, ging ein Fußulkus voraus, das im weiteren Verlauf eine schwere Infektion oder Gangrän ausbildete (International Working Group on the Diabetic Foot 2007; Boulton et al. 2005; Apelqvist und Larsson 2006).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJM (1998) Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 21:1071–1076

    Article  CAS  Google Scholar 

  • Abbott CA, Carrington AL, Ashe H et al (2002) The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19(5):377–384

    Article  CAS  Google Scholar 

  • Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H, BASIL trial participants (2005) Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366:1925–1934

    Article  CAS  Google Scholar 

  • Adler AI, Boyko EJ, Ahroni JH, Smith DG (1999) Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 22:1029–1035

    Article  CAS  Google Scholar 

  • Andros G (2004) Diagnostic and therapeutic arterial intervention s in the ulcerated diabetic foot. Diabetes/Metabolism Res Rev 20(Suppl 1):29–33

    Article  Google Scholar 

  • Annersten M, Eneroth M, Larsson J, Nyberg P Thörne J, Apelqvist J (2008) Complexity of factors related to outcome of neuropathic and neuroischemic/ischemic diabetic foot ulcers. Diabetologia 2008. [Epub vor Druck]

    Google Scholar 

  • Apelqvist J (1998) Wound healing in diabetes. Outcome and costs. Clin Podiatr Med Surg 15:21–39

    CAS  PubMed  Google Scholar 

  • Apelqvist J, Larsson J (2006) What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 16(Suppl 1):S75–S83

    Google Scholar 

  • Apelqvist J, Larsson J, Agardh CD (1993) Long term prognosis for diabetic patients with foot ulcer. J Int Med 233:485–491

    Article  CAS  Google Scholar 

  • Armstrong DG, Lavery LA, Harkless LB (1998) Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21:855–859

    Article  CAS  Google Scholar 

  • Armstrong DG, Lavery LA, Diabetic Foot Study Consortium (2005) Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 366:1704–1710

    Article  Google Scholar 

  • Beckert S, Witte M, Wicke C, Königsrainer A, Coerper S (2006) A new wound-based severity score for diabetic foot ulcers. Diabetes Care 29:988–992

    Article  Google Scholar 

  • Belch J, Hiatt WR, Baumgartner I et al (2011) Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischemia. Lancet 377:1929–1937

    Article  CAS  Google Scholar 

  • Berend AR, Peters EJG, Bakker K (2008) Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 24(Suppl 1):S145–S161

    Article  Google Scholar 

  • Blume PA, Walters J, Payne W, Ayala J, Lantis J (2008) Comparisons of negative pressure wound therapy using vacum assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomised controlled trial. Diabetes Care 31(4):631–636

    Article  Google Scholar 

  • Boulton AJ (2004) The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 47(8):1343–1353

    Article  CAS  Google Scholar 

  • Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global burden of diabetic foot disease. Lancet 366(9498):1719–1724

    Article  Google Scholar 

  • Boyko EJ, Ahroni J, Cohen V, Nelson K, Heagerity P (2006) Prediction of diabetic foot ulcer occurrence using common available clinical information – The Seattle Diabetic Foot Study. Diabetes Care 29:1202–1207

    Article  Google Scholar 

  • Bus A, Valk GD, van Deursen RWD et al (2008) The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes a systematic review. Diabetes Metab Res Rev 24(Suppl 1):162–180

    Article  Google Scholar 

  • Carrington AL, Mawdsley SK, Morley M, Kincey J, Boulton AJ (1996) Psychological status of diabetic patients with or without lower limb disability. Diabetes Res Clin Pract 32:19–25

    Article  CAS  Google Scholar 

  • Clinical guidelines for Type 2 Diabetes. Prevention and management of foot problems. NICE 2004. www.nice.org.uk

  • Connor H, Mahdi OZ (2004) Repetitive ulceration in neuropathic patients. Diabetes Metab Res Rev 20(Suppl 1):23–28

    Article  Google Scholar 

  • Dargis V, Pantelejeva O, Jonushaite A, Boulton A, Vileikyte I (1999) Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care 22(9):1428–1431

    Article  CAS  Google Scholar 

  • Del Aguila MA, Reiber G, Koepsell T (1994) How does provider and patient awareness of high-risk status for lower extremity amputation influence foot care practice? Diabetes Care 17:1050–1054

    Article  Google Scholar 

  • Eneroth M, Larsson J, Apelqvist J (1999) Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Complications 13(5–6):254–263

    Article  CAS  Google Scholar 

  • Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R, Pritelli C, Clerici G, Fratino P, De Cata P, Dalla Paola L, Mariani G, Poli M, Settembrini PG, Sciangula L, Morabito A, Graziani L (2002) Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 252:225–232

    Article  CAS  Google Scholar 

  • Fletcher E, MacFarlane RM, Jeffcoate WJ (1992) Can foot ulcers pe prevented by education ? Diabetes Medicine 2(Suppl 2):41–42

    Google Scholar 

  • Hinchliffe RJ, Valk GD, Apelqvist J et al (2008) A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 24(Suppl 1):119–144

    Article  Google Scholar 

  • Hjelm K, Nyberg P, Apelqvist J (2003) The influence of beliefs about health and illness on foot care in diabetic subjects with severe foot lesions: a comparison of foreign and Swedish-born individuals. Clin Eff Nurs 7(1):1–14

    Article  Google Scholar 

  • Houtum WH van, Lavery L (1996) Outcomes associated with diabetes related amputations in the Netherlands and in the state of California USA. J Intern Med 240: 227–231

    Google Scholar 

  • Iilda O, Soga Y, Hiramo K et al (2012) Long-term results of direct and indrect endovascularisation based on the angiosome-concept in patients with critical limb ischemia presenting with below-the-knee-lesion. J Vasc Surg 55:363–370

    Article  Google Scholar 

  • International Working Group on the Diabetic Foot (2007) International Consensus on the Diabetic Foot and Practical Guidelines on the Management and the Prevention of the Diabetic Foot. International Working Group on the Diabetic Foot, Amsterdam, the Netherlands, on CD-ROM. www.idf.org/bookshop

  • Jacqueminet S, Hartemann-Heurtier A, Izzillo R, Cluzel P, Golmard JL, Ha Van G, Koskas F, Grimaldi A (2005) Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors. Diabetes Metab 31:370–375

    Article  CAS  Google Scholar 

  • Jaff MR, White CJ, Hiatt WR et al (2015) An update on methods for revascularisation and expansion of the TASC lesion classification to include below-the – knee arteries: a supplement to the Inter-Society Consensus for the management of the peripheral arterial disease. J Endovasc Ther. https://doi.org/10.1177/15266028115592206

  • Jeffcoate W, Harding K (2003) Diabetic foot ulcers. Lancet 361:1545–1551

    Article  Google Scholar 

  • Jeffcoate W, Game F, Cavanagh P (2005) The role of proinflammatory cytokines in the cause of neuropathic osteoartropathy (acute Charcot foot) in Diabetes. Lancet 366:2058–2061

    Article  CAS  Google Scholar 

  • Jeffcoate WJ, Chipchase SY, Ince P, Game FL (2006) Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care 29:1784–1787

    Article  Google Scholar 

  • Kalani M, Brismar K, Apelqvist J, Eliasson B, Eriksson J, Fagrell B, Jörneskog B (2003) Effect of Daltiperin on healing of chronic foot ulcers in diabetic patients with pheripheral arterial occlusive disease – prospective, randomized, double blind and placebo controlled study. Diabetes Care 6:2575–2580

    Article  Google Scholar 

  • Kröger K, Moysidis T, Fegjaly M et al (2014) Association of diabetic foot care and amputation rates in Germany. Int Wound J. https://doi.org/10.1111/iwj.1234

  • Lavery LA, Armstrong D, Wunderlich R, Mohler M, Wendel C, Lipsky B (2006) Risk factors for Ioot infections in individuals with diabetes. Diabetes Care 29:1288–1293

    Article  Google Scholar 

  • Lipsky B (2004) A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev 20(Suppl 1):68–77

    Article  Google Scholar 

  • Lipsky B, Berent Ar, Embil J, de Lalla F (2004) Diagnosing and treating diabetic foot infections. Diabetes Metab Res Rev 20(Suppl 1):56–64

    Article  Google Scholar 

  • Macfarlane RM, Jeffcoate WJ (1997) Factors contributing to the presentation of diabetic foot ulcers. Diabet Med 14(10):867–870

    Article  CAS  Google Scholar 

  • Mantey I, Foster AVM, Spencer S, Edmonds ME (1999) Why do foot ulcers recur in diabetic patients? Diabet Med 16:245–249

    Article  CAS  Google Scholar 

  • Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA (2000) Risk factors for delayed healing of neuropathic diabetic foot ulcers: a pooled analysis. Arch Dermatol 136:1531–1535

    CAS  PubMed  Google Scholar 

  • Margolis DJ, Gelfand JM, Hoffstad O, Berlin JA (2003) Surrogate end points for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 26:1696–1700

    Article  Google Scholar 

  • Marston WA (2006) Risk factors associated with healing chronic diabetic foot ulcers: the importance of hyperglycaemia. Ostomy Wound Manage 52:26–28

    PubMed  Google Scholar 

  • McCabe CJ, Stevenson RC, Dolan AM (1998) Evaluation of diabetic foot screening and protection programme. Diabtes Med 15:80–84

    Article  CAS  Google Scholar 

  • Mills JL (2008) Open bypass and endoluminal therapy: complementary techniques for revascularisation in diabetic patients with critical limb ischemia. Diabetes/Metabolism Res Rev 24(Suppl 1):34–39

    Article  Google Scholar 

  • Mills JL, Beckett WC, Taylor SM (1991) The diabetic foot: consequences of delayed treatment and referral. South Med J 84(8):970–974

    Article  CAS  Google Scholar 

  • Muller I, De Graw W, Van Gerwin W, Bartelink M, Van Den Hoogen, Rutten G (2002) Foot ulceration and lower limb amputation in Dutch Primary Health Care. Diabetes Care 25:570–574

    Article  Google Scholar 

  • Nabuurs-Franssen MH, Huijberts MS, Nieuwenhuijzen Kruseman AC, Willems J, Schaper NC (2005) Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia 48(9):1906–1910

    Article  CAS  Google Scholar 

  • Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, on behalf of the TASC II Working Group (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45(1 Suppl):S5–S67

    Article  Google Scholar 

  • Ortegon MM, Redekop WK, Niessen LW (2002/2004) Cost-effectiveness of prevention and treatment of the diabetic foot. Diabetes Care 27:901–907

    Google Scholar 

  • Morris AD, McAlpine R, Steinke D, Boyle DIR, Ebrahim A-R, Vasudev N, Stewart CPU, Jung RT, Leese GP, MacDonald TM, Newton RW (1998) Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration, Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care 21:738–743

    Article  CAS  Google Scholar 

  • Price P, Harding K (2000) The impact of foot complications on health related quality of life in patients with diabetes. J Cutaneous Med Surg 4:45–50

    Article  CAS  Google Scholar 

  • Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, van Baal J, van Merode F, Schaper N (2007) High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 50(1):18–25

    Article  CAS  Google Scholar 

  • Prompers L, Schaper N Apelqvist J, Jude E, Piaggesi A, Bakker K, Edmonds M, Holstein P, Jirkovska A, Mauricio D, Ragnarson Tennvall G, Reike H, Spraul M, Uccioli L, Urbancic V, Van Acker K, van Baal J, van Merode F, Huijberts M (2008) Prediction of outcome in individuals with diabetic foot ulcers: focus on between individuals with and without peripheral vascular disease. The EURODIALE study. Diabetologia 51:747–755

    Article  CAS  Google Scholar 

  • Pscherer S, Dipple FW, Lauterbachs S et al (2012) Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany. Prim Care Diabetes 6:241–246

    Article  Google Scholar 

  • Ragnarson Tennvall G, Apelqvist J (2004) Health-economic consequences of diabetic foot lesions. Clin Infect Dis 39(Suppl 2):S132–S139

    Article  Google Scholar 

  • Ragnarson Tennvall G, Apelqvist J (2001) Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia 44:2077–2087

    Article  CAS  Google Scholar 

  • Ragnarsson Tennvall G, Apelqvist J (2000) Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications 14:235–241

    Article  Google Scholar 

  • Rauner MS, Heidenberger K, Pesendorfer E-M (2004) Using a Markov model to evaluate the cost-effectiveness of diabetic foot prevention strategies in Austria. In: SCS, the Society for Modeling Simulation International. Wiley

    Google Scholar 

  • Reinecke H, Unrath M, Freisinger E et al (2015) Peripheral arterial disease and critical limb ischemia: still poor outcomes and lack of guideline adherence. Eur Heart J 36:932–938

    Article  Google Scholar 

  • Schaper NC, Nabuurs-Franssen MH, Huijberts SP (2000) Peripheral vascular disease and type 2 Diabetes mellitus? Diabetes Metab Res Rev 16(Suppl 1):11–15

    Article  Google Scholar 

  • Schaper NC, Apelqvist J, Bakker K (2003) The international consensus and practical guidelines on the management and prevention of the diabetic foot. Curr Diab Rep 3(6):475–479

    Article  Google Scholar 

  • Soderström M et al (2013) Angiosome-targeted infrapopliteal endovascular revascularisation for the treatment of diabtic foot ulcers. J Vasc Surg 57:427–435

    Article  Google Scholar 

  • Teraa M, Sprangers RW, Schutgens RE et al (2015) Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous intra-arterial Supplemention (JUVENTAS) trial. Circulation 131:851–860

    Article  CAS  Google Scholar 

  • Trepman E, Nihal A, Pinzur M (2005) Charcot neuroarthropathy of the foot and ankle. Foot and Ankle 26:46–63

    Article  Google Scholar 

  • Vileikyte I (2001) Diabetic Foot ulcers: a quality of life issue. Diab Metab Rev Res 17:246–249

    Article  CAS  Google Scholar 

  • Vileikyte I, Robin RR, Leventhal H (2004) Psychological aspects of diabetic neuropathic foot complications: an overview. Diabetes Metab Rev Res 20(Suppl 1):13–18

    Article  Google Scholar 

  • Walsh CH (1996) A healed ulcer: what now. Diabet Med 13:58–60

    Article  Google Scholar 

  • Walter DH, Krankenberg H, Balzer JO et al (2011) Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circulation Cardiovasc Interv 4:26–37

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, University Hospital of Malmö, Malmö, Schweden

    Jan Apelqvist

  2. Praxis für Herzkreislauf-Erkrankungen, Dr. H. Lawall und Prof Dr. Curt Diehm, Ettlingen, Deutschland

    Holger Lawall

  3. Klinik und Poliklinik für Gefäßmedizin, Universitäres Herz- und Gefäßzentrum Hamburg, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland

    Eike Sebastian Debus

Authors
  1. Jan Apelqvist
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Holger Lawall
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eike Sebastian Debus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eike Sebastian Debus .

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Gefäßmedizin, Universitäres Herzzentrum GmbH, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

    Eike Sebastian Debus

  2. Radiologie, Allgemeines Krankenhaus Harburg Abt. Diagnostische und Interventionelle, Hamburg, Germany

    Walter Gross-Fengels

Section Editor information

  1. Klinik und Poliklinik für Gefäßmedizin, Universitäres Herzzentrum Hamburg, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland

    Eike Sebastian Debus

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Apelqvist, J., Lawall, H., Debus, E.S. (2019). Diabetischer Fuß. In: Debus, E., Gross-Fengels, W. (eds) Operative und interventionelle Gefäßmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45856-3_119-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45856-3_119-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45856-3

  • Online ISBN: 978-3-662-45856-3

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation